Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia

Published:2022-01-02 Issue: Volume: Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Tong Wing H.¹²^ORCID,Mesegué Montserrat³⁴,Dapena José Luís³⁴,Camós Mireia⁴⁵⁶,Rives Susana³⁴⁵

Affiliation:

1. Department of Public Health and Primary Care (PHEG) Leiden University Medical Center Leiden The Netherlands

2. Argos Zorggroep “DrieMaasStede”, Center for Specialized Geriatric Care Schiedam The Netherlands

3. Pediatric Hematology and Oncology Departments Hospital Sant Joan de Déu, University of Barcelona Barcelona Spain

4. Leukemia and Other Pediatric Hemopathies, Developmental Tumor Biology Group, Institut de Recerca Hospital Sant Joan de Déu Barcelona Barcelona Spain

5. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III Madrid Spain

6. Hematology Laboratory Hospital Sant Joan de Déu, University of Barcelona Barcelona Spain

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2960

Reference16 articles.

1. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study

2. Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16

3. Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study

4. Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia

5. Efficacy and toxicity of pegaspargase and calaspargase pegol in childhood acute lymphoblastic leukemia: results of DFCI 11‐001;Vrooman LM;J Clin Oncol,2021